Advertisement

Advertisement

Most Viewed Videos
Ryan Huey, MD, on the Financial Toxicity of Early-Phase Clinical Trials
Bernardo H.L. Goulart, MD, on Stage IV NSCLC: High Drug Costs May Affect Survival
Linda D. Bosserman, MD, on Pathways for Personalized Precision Medicine and Value
Lauren M. Hamel, PhD, on Race and Doctor-Patient Behavior
Elena Martinez, PhD, MPH, on Diversity in Precision Oncology
Cristina Merkhofer, MD, MHS, on NSCLC: Survival Impact of Taking Part in a Clinical Trial
Mallika Sharma, MPH, on Eliminating Prior Authorizations, Anxiety, Delay in Care, Higher Costs
Margaret A. Tempero, MD, on Pancreatic Cancer: NCCN Guidelines Updates
Grace C. Hillyer, EdD, MPH, on Enrolling Patients in Clinical Trials: Improving Clinician-Patient Communication
Nadine Housri, MD, on Online Tumor Boards: A New Resource for Practicing Oncologists
Karen M. Winkfield, MD, PhD, on Policy and Business Solutions to Address Disparities in Cancer Care
Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib
Angela M. Stover, PhD, on Patient-Reported Outcome Performance Measures for Oncology Practice
Manali I. Patel, MD, on Community Practices: Enhancing Delivery of Value-Based Cancer Care
Francesca Battaglin, MD, on Colorectal Cancer: Using Genetic Variants to Predict Treatment Efficacy
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: New Immunotherapy Strategies in the NCCN Guidelines
Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Building on Recent Successes
Matthew B. Schabath, PhD, on Addressing Cultural Barriers to Equality in Oncology Among Sexual Gender Minorities
Hope S. Rugo, MD, on Immunotherapy for Breast Cancer: Expert Perspective

Advertisement

Advertisement



Advertisement